Biofidelity to Launch Enspyre Technology
Biofidelity is launching Enspyre, a novel target enrichment technology that significantly enhances NGS efficiency.
Read MorePosted by Chris Wolski | Feb 20, 2025 | Molecular Diagnostics |
Biofidelity is launching Enspyre, a novel target enrichment technology that significantly enhances NGS efficiency.
Read MorePosted by Chris Wolski | Feb 20, 2025 | Microscopy |
Thermo Fisher has launched the Invitrogen EVOS S1000 Spatial Imaging System, enabling high-quality multiplex imaging of multiple samples.
Read MorePosted by Chris Wolski | Feb 19, 2025 | Company News |
Baylor Genetics celebrates its 10-year anniversary, highlighting its leadership in precision diagnostics and innovative genetic testing.
Read MorePosted by Chris Wolski | Feb 18, 2025 | Prenatal Testing |
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Read MorePosted by Chris Wolski | Feb 18, 2025 | Womens Health |
Roche’s Elecsys sFlt-1/PlGF test received FDA clearance, providing a prognostic way to help ID pregnant women at risk of severe preeclampsia.
Read More